You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

non-insulin dependant diabetes

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes Trial in New York, Charlottesville (Continuous Glucose Monitoring (CGM)-based titration algorithm implemented in

Not yet recruiting
  • Type 2 Diabetes
  • Continuous Glucose Monitoring (CGM)-based titration algorithm implemented in DiAs
  • New York, New York
  • +1 more
Nov 2, 2023

Diabetes, Diabete Type 2 Trial in Reno (Dayamed Arthur a novel intelligent medication adherence platform)

Completed
  • Diabetes
  • Diabete Type 2
  • Dayamed Arthur a novel intelligent medication adherence platform
  • Reno, Nevada
    VA Sierra Nevada Health Care System
Mar 15, 2023

Type 2 Diabetes, Insulin Independent Trial in Stockholm (morning HIIT --> afternoon HIIT, afternoon HIIT --> morning HIIT)

Withdrawn
  • Type 2 Diabetes
  • Insulin Independent
  • morning HIIT --> afternoon HIIT
  • afternoon HIIT --> morning HIIT
  • Stockholm, Sweden
    Karolinska Institutet
May 23, 2022

Type 2 Diabetes, NAFLD Trial (Drinking powder supplement)

Not yet recruiting
  • Type 2 Diabetes
  • NAFLD
  • Drinking powder supplement
  • (no location specified)
Dec 8, 2022

Non-insulino-dependant Diabetes in Infants and Teenagers

Recruiting
  • Diabetes
  • Pediatric Disorder
    • Saint-Benoît, France
    • +3 more
    Nov 23, 2021

    Diabetes, Type 2 Trial (Revita® DMR Treatment, Sham procedure)

    Not yet recruiting
    • Diabetes Mellitus, Type 2
    • Revita® DMR Treatment
    • Sham procedure
    • (no location specified)
    Oct 18, 2023

    Diabetes, Type 2 Trial (Intermittently scanned continuous glucose monitor (isCGM), Education and individualized feedback)

    Recruiting
    • Diabetes Mellitus, Type 2
    • Intermittently scanned continuous glucose monitor (isCGM)
    • Education and coaching
    • Edmonton, Alberta, Canada
      University of Alberta Hospital / Kaye Edmonton Clinic
    Oct 6, 2022

    Weight Loss, Metabolic Syndrome, Diabetes, Type 2 Trial in Palo Alto (Continuous Glucose Monitor Device)

    Recruiting
    • Weight Loss
    • +6 more
    • Continuous Glucose Monitor Device
    • Palo Alto, California
      Signos
    May 24, 2023

    Type 2 Diabetes Trial in Exeter (Dietary Intervention)

    Recruiting
    • Type 2 Diabetes
    • Dietary Intervention
    • Exeter, Devon, United Kingdom
      Nutritional Physiology Research Unit
    Nov 7, 2022

    Obesity, Liver Diseases, Liver Fibrosis Trial in Boston (ESG, GLP1-RA)

    Not yet recruiting
    • Obesity
    • +16 more
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Nov 14, 2023

    Obesity, Pre Diabetes, Diabetes, Type 2 Trial in Hattiesburg (Ketone Ester Supplement, Placebo)

    Recruiting
    • Obesity
    • +3 more
    • Ketone Ester Supplement
    • Placebo
    • Hattiesburg, Mississippi
      University of Southern Mississippi - School of Kinesiology and N
    Dec 6, 2022

    Nonalcoholic Steatohepatitis (NASH) Trial in Gent (ORMD-0801 QD, ORMD-0801 BD)

    Completed
    • Nonalcoholic Steatohepatitis (NASH)
    • ORMD-0801 QD
    • ORMD-0801 BD
    • Gent, Belgium
      Universitaire Ziekenhuis Gent
    Sep 15, 2022

    Type 2 Diabetes (T2DM) Trial in Germany

    Recruiting
    • Type 2 Diabetes Mellitus (T2DM)
      • Germany, Germany
        Investigational site
      Nov 21, 2022

      Diabetes, Non Insulin Dependent Diabetes Trial in New York (Telehealth Bridge Visits, Standard of Care)

      Not yet recruiting
      • Diabetes Mellitus
      • Non Insulin Dependent Diabetes Mellitus
      • Telehealth Bridge Visits
      • Standard of Care
      • New York, New York
        NYU Langone Health
      Jun 2, 2023

      Insulin Resistance, Prediabetic State, Non-Alcoholic Fatty Liver Disease Trial in New York (drug, other, dietary supplement,

      Not yet recruiting
      • Insulin Resistance
      • +3 more
      • Insulin human
      • +11 more
      • New York, New York
        Columbia University Irving Medical Center
      Nov 6, 2023

      Type 2 Diabetes, Postprandial Hyperglycemia Trial in Stockholm (Insulin aspart (Novorapid®))

      Completed
      • Type 2 Diabetes Mellitus
      • Postprandial Hyperglycemia
      • Insulin aspart (Novorapid®)
      • Stockholm, Sweden
        Department of Medicine, Clinical pharmacology Unit, Karolinska U
      May 24, 2022

      Normoglycemia, T2DM (Type 2 Diabetes) Trial in New Delhi (Bread, Mango)

      Completed
      • Normoglycemia
      • T2DM (Type 2 Diabetes Mellitus)
      • Bread
      • Mango
      • New Delhi, Delhi, India
        Fortis CDOC Hospital
      Sep 20, 2023

      Type 2 Diabetes, Nephropathy Trial (MK0954, losartan / Duration of Treatment: mean 3.4 years, Placebo / Duration of Treatment:

      Completed
      • Type 2 Diabetes
      • Nephropathy
      • MK0954, losartan / Duration of Treatment: mean 3.4 years
      • Placebo / Duration of Treatment: mean 3.4 years
      • (no location specified)
      Feb 7, 2022

      Looking at Blood Sugar Control in People With Type 2 Diabetes

      Not yet recruiting
      • Diabetes Mellitus, Type 2
      • (no location specified)
      Jul 27, 2022

      Type 2 Diabetes Trial in León (NPH insulin, Glargine and Lispro insulin)

      Completed
      Has Results
      • Type 2 Diabetes Mellitus
      • NPH insulin
      • Glargine and Lispro insulin
      • León, Guanajuato, Mexico
        Hospital General de León
      Nov 3, 2021

      Glycaemic Control and Other Clinical Parameters in Adult Type 2

      Completed
      • Diabetes Mellitus, Type 2
      • Medellín, Antioquia, Colombia
      • +5 more
      Nov 4, 2022

      Saudi Arabia to Understand How Dose Check App Used With Tresiba

      Not yet recruiting
      • Diabetes Mellitus, Type 2
      • Insulin degludec
      • Al Khobar, Saudi Arabia
      • +6 more
      Nov 23, 2023

      A Pan-European Post-Authorisation Safety Study: Risk of

      Not yet recruiting
      • Pancreatic Cancer
      • Exenatide
      • Non-GLP-1 RA based glucose lowering drugs
      • (no location specified)
      Dec 21, 2022

      Diabetes, Type 2, NASH - Nonalcoholic Steatohepatitis Trial in Tustin, Jerusalem, Tel Aviv (ORMD-0801 (Insulin) capsule 8 mg BD,

      Completed
      • Diabetes Mellitus, Type 2
      • NASH - Nonalcoholic Steatohepatitis
      • ORMD-0801 (Insulin) capsule 8 mg BD
      • Placebo
      • Tustin, California
      • +2 more
      Sep 13, 2022

      Diabetes, Type 2, Glucose Trial in Canada (FreeStyle Libre Flash Glucose Monitor, Diabetes self-management education)

      Active, not recruiting
      • Diabetes Mellitus, Type 2
      • Glucose
      • FreeStyle Libre Flash Glucose Monitor
      • Diabetes self-management education
      • Brampton, Ontario, Canada
      • +5 more
      Feb 4, 2022